Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Alkermes Plc (ALKS)
Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,315,543
  • Shares Outstanding, K 166,881
  • Annual Sales, $ 1,112 M
  • Annual Income, $ -158,270 K
  • 60-Month Beta 0.64
  • Price/Sales 3.93
  • Price/Cash Flow 103.66
  • Price/Book 3.22
Trade ALKS with:

Options Overview Details

View History
  • Implied Volatility 32.12% ( -1.17%)
  • Historical Volatility 35.31%
  • IV Percentile 35%
  • IV Rank 15.65%
  • IV High 94.65% on 12/09/22
  • IV Low 20.52% on 11/28/23
  • Put/Call Vol Ratio 0.96
  • Today's Volume 53
  • Volume Avg (30-Day) 526
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 12,782
  • Open Int (30-Day) 14,658

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.32
  • Number of Estimates 5
  • High Estimate 0.75
  • Low Estimate 0.06
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +1,700.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.06 +17.23%
on 11/16/23
26.98 -4.15%
on 12/06/23
+1.08 (+4.36%)
since 11/08/23
3-Month
22.01 +17.49%
on 10/25/23
30.97 -16.50%
on 09/13/23
-2.99 (-10.36%)
since 09/08/23
52-Week
22.01 +17.49%
on 10/25/23
33.71 -23.29%
on 06/26/23
+0.38 (+1.49%)
since 12/08/22

Most Recent Stories

More News
3 Top Growth Stocks to Buy for December 2023

Here are three of the best growth stocks to buy right now, based on solid earnings performance, encouraging 2024 forecasts, and enthusiastic ratings from Wall Street analysts.

ALKS : 25.86 (-1.15%)
FROG : 29.77 (+2.37%)
FOUR : 67.40 (+2.65%)
Biogen (BIIB) Earnings Spotlight: Is the Biotech Stock a Buy or Sell?

Biotech major Biogen (BIIB) will report its third-quarter results on November 8. Its EPS and revenue are expected to decline year-over-year. However, the FDA approvals for new drugs received by the company...

ALKS : 25.86 (-1.15%)
BIIB : 239.29 (+0.07%)
GILD : 79.02 (+1.24%)
JAZZ : 120.42 (+0.73%)
Amgen (AMGN) Earnings Watch: Buy or Sell?

Amgen (AMGN) is scheduled to report its third-quarter earnings soon, with Wall Street analysts expecting year-over-year improvements in revenue. However, its earnings are expected to miss the consensus...

ALKS : 25.86 (-1.15%)
AMGN : 269.12 (-0.81%)
GILD : 79.02 (+1.24%)
JAZZ : 120.42 (+0.73%)
Why Alkermes Stock Is Sinking Today

The biotech company's Q3 revenue and earnings looked great, but the results weren't enough to wow investors.

ALKS : 25.86 (-1.15%)
Alkermes: Q3 Earnings Snapshot

Alkermes: Q3 Earnings Snapshot

ALKS : 25.86 (-1.15%)
Alkermes to Report Third Quarter Financial Results on October 25, 2023

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, Oct. 25, 2023 to...

ALKS : 25.86 (-1.15%)
Exploring the Upside Potential of 3 Biotech Stocks

Given the breakthrough developments, government support, and rising need to treat chronic diseases, the biotech industry is well-positioned to grow steadily. So, it could be wise to invest in quality biotech...

ALKS : 25.86 (-1.15%)
AMGN : 269.12 (-0.81%)
INCY : 54.70 (-0.87%)
Mural Oncology to Host Investor Webcast on October 17

/PRNewswire/ -- Mural Oncology plc, the publicly-traded oncology company that Alkermes plc (Nasdaq: ALKS) plans to establish in the fourth quarter of 2023...

ALKS : 25.86 (-1.15%)
Alkermes to Present First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present new data related to ALKS 2680, the company's novel, investigational orexin 2...

ALKS : 25.86 (-1.15%)
Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual...

ALKS : 25.86 (-1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major...

See More

Key Turning Points

3rd Resistance Point 26.84
2nd Resistance Point 26.60
1st Resistance Point 26.23
Last Price 25.86
1st Support Level 25.62
2nd Support Level 25.38
3rd Support Level 25.01

See More

52-Week High 33.71
Fibonacci 61.8% 29.24
Fibonacci 50% 27.86
Fibonacci 38.2% 26.48
Last Price 25.86
52-Week Low 22.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar